Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Jul 29, 2019
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
Policy Notices
- Extension of Certain Flexibilities for Prospective Basic Experimental Studies With Human Participants
National Institutes of Health
- Changes to NIH Requirements Regarding Proposed Human Fetal Tissue Research
National Institutes of Health
General Notices
- Notice of Informational Webinar for PAR-19-301 Limited Competition: NIGMS National and Regional Resources (R24 Clinical Trial Not Allowed)
National Institute of General Medical Sciences
- Consolidated Notice on NIMH Clinical Trials Policies
National Institute of Mental Health
- Registration Open for the ICARE Academy on September 10-11, 2019, in Alexandria, VA
National Institutes of Health
- Notice of System Change and Procedure for Requesting an Extension to Early Stage Investigator (ESI) Status
National Institutes of Health
- Request for Information (RFI): Swallowable Smart Pills or Devices to Enable Precision Nutrition, Microbiome and Gastroenterological Research
National Institute of Diabetes and Digestive and Kidney Diseases
Notice of Changes to Funding Opportunities
- Notice of Correction to PAR-19-314 "NIA Program Project Applications (P01 Clinical Trial Optional)"
National Institute on Aging
- Notice of Clarification to PAR-18-841, "Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24 - Clinical Trial Optional)"
National Cancer Institute
- Notice of Clarification of Program Director/Principal Investigator Eligibility for PAR-19-102 Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32)
National Institute of General Medical Sciences
- Notice of Clarification of Program Director/Principal Investigator Eligibility for PAR-19-218 Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34)
National Institute of General Medical Sciences
- Notice of Clarification of Eligibility for PAR-19-286 "Postdoctoral Research Associate Training (PRAT) Program (Fi2)
National Institute of General Medical Sciences
Notices of Intent to Publish
- Notice of Intent to Publish the Reissuance of RFA-CA-18-026, "Improving the Reach and Quality of Cancer Care in Rural Populations (R01 Clinical Trial Required)"
National Cancer Institute
Funding Opportunities
- Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01-Clinical Trial Optional)
National Institute on Drug Abuse
- Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Independent Clinical Trial Not Allowed)
- Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required)
National Institute on Aging
- Microbiome and Aging: Impact on Health and Disease (R01 Clinical Trial Not Allowed)
National Institute on Aging
- Preclinical Screening for Natural Product Drug Interactions (Clinical Trial Not Allowed, R21)
National Center for Complementary and Integrative Health
- Center of Excellence for Natural Product Drug interaction Research (U54, Clinical Trial Required)
National Center for Complementary and Integrative Health
- (Re)Building a Kidney (UC2 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Lynn Hudachek at lynn-hudachek @uiowa.edu